Evidence map›Paper›PMID 29959557›Full record

ArticleInternational journal of legal medicine2019

Mass poisoning with NPS: 2C-E and Bromo-DragonFly.

S Iwersen-Bergmann, S Lehmann, A Heinemann, C Schröder, A Müller, H Jungen, H Andresen-Streichert, K Pueschel, C Vidal, K Mercer-Chalmers-Bender

Erratum issuedAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of legal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Machine learningRSC advances · 2021
    Article
  3. Article
  4. Review
  5. New psychoactive substances: a review and updates.Therapeutic advances in psychopharmacology · 2020
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

S Iwersen-BergmannDepartment of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. s.iwersen-bergmann@uke.de.ORCID http://orcid.org/0000-0001-7687-1388
S LehmannInstitute of Legal Medicine, University Hospital of Cologne, Cologne, Germany.
A HeinemannDepartment of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
C SchröderDepartment of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
A MüllerDepartment of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
H JungenDepartment of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
H Andresen-StreichertDepartment of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
K PueschelDepartment of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
C VidalForensic Science Institute, State Criminal Police Office of Lower Saxony, Hannover, Germany.
K Mercer-Chalmers-BenderInstitute of Legal Medicine, University Hospital of Cologne, Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReports of intoxications with new psychoactive substances (NPS) mostly involve young people, as they are the main consumers of these types of drugs. This report centers on a case that was unusual due to it being a mass-poisoning event involving middle-aged individuals who had consumed a combination of the two different new psychoactive drugs 2,5-dimethoxy-4-ethylphenethylamine (2C-E) and 1-(8-bromofuro[2,3-f][1]benzofuran-4-yl)-2-propanamine (Bromo-DragonFly, BDF). CASE HISTORY: The mass poisoning of 29 individuals (24-56 years old) resulted in their admission to six different hospitals with severe symptoms of intoxication. All symptoms manifested after consumption of an unknown drug formulation around lunchtime during an esoteric weekend seminar. INVESTIGATION: Urine (n = 11) and blood samples (n = 29), collected from the 29 individuals for police investigation, were analyzed with immunochemical techniques, GC/MS and LC-MS/MS. 2C-E was confirmed in seven urine samples, but not in blood. BDF was confirmed in all urine samples, and in 17 blood samples. The blood samples exhibited BDF concentrations between ca. 0.6 and ca. 2.0 μg/L, while urine concentrations of BDF ranged from ca. 1.6 to 35 μg/L. The concentration of 2C-E in urine was found to be between ca. 1.5 and 183 μg/L. All patients made a complete recovery, although some had required mechanical ventilation.

conclusionThe investigation and the presentation of this case illustrates not only mass intoxication with 2C-E and BDF, with corresponding blood and urine concentrations, but also the necessity of collecting urine samples in cases where NPS-consumption is suspected, in order to improve the chances of analytical detection.

Indexed as

AdultAnisolesBromobenzoatesChromatography, LiquidFemaleGas Chromatography-Mass SpectrometryHumansIllicit DrugsMaleMiddle AgedMolecular StructurePropylaminesPsychotropic DrugsSulfides1-(8-bromobenzo(1,2-b;4,5-b')difuran-4-yl)-2-aminopropane2,5-dimethoxy-4-ethylthiophenethylamineAnisolesBromobenzoatesIllicit DrugsPropylaminesPsychotropic DrugsSulfides2C-EBloodBromo-DragonFlyConcentrationMass poisoningUrine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.